心内膜心肌活检在儿童与成人心肌炎中的安全性与预后价值:ESC EORP 心肌病与心肌炎长期注册研究
心内膜心肌活检在儿童与成人中并发症率低且无操作相关死亡;心脏磁共振Lake Louise标准敏感性较低,尤其儿童。诊断时较低左室射血分数和需使用免疫抑制剂是不良预后的独立预测因素。
要点
- 心内膜心肌活检在儿童与成人中并发症率相似且无操作相关死亡。
- 心脏磁共振Lake Louise标准在活检证实心肌炎中敏感性较低,儿童尤甚。
- 诊断时较低左室射血分数和需免疫抑制剂是不良预后的独立预测因素。
核心结论
- 心内膜心肌活检安全,心脏磁共振Lake Louise标准敏感性较低尤其儿童。
- 病毒阴性淋巴细胞性心肌炎在儿童和成人中均占主导,免疫抑制治疗使用率低。
- 诊断时较低左室射血分数和需免疫抑制剂是1年不良结局事件的独立预测因素。
研究设计与样本
- 欧洲心脏病学会EURObservational Research Programme心肌病与心肌炎长期注册研究。
- 分为3组:组1(n=233)临床疑似心肌炎伴心脏磁共振异常;组2(n=222)活检证实心肌炎;组3(n=126)临床疑似心肌炎伴正常/不确定/未行心脏磁共振。
主要发现
- 心内膜心肌活检(主要为右心室)在儿童与成人中并发症率相似(4.7% vs 4.9%,P=NS),无操作相关死亡。
- 1年随访:410例中11例(2.7%)死亡,7例(1.7%)接受心脏移植,3例(0.7%)植入VAD,16例(3.9%)植入ICD。
关键数值与推荐
- 心肌炎诊断基于2013年欧洲心脏病学会标准。
- 1年不良结局事件包括死亡/心脏移植、VAD或ICD植入、因心脏原因住院。
- 独立预测因素为较低左室射血分数和因新诊断心肌炎对非病因驱动治疗无效而需使用免疫抑制剂。
临床怎么用
- 心内膜心肌活检在儿童和成人中均可安全实施,右心室活检并发症率低且无操作相关死亡。
- 心脏磁共振Lake Louise标准在儿童中敏感性较低,阴性结果不能排除活检证实的心肌炎。
- 诊断时较低左室射血分数和需免疫抑制剂提示1年不良结局风险较高,应加强随访管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Contemporary multicentre data on clinical and diagnostic spectrum and outcome in myocarditis are limited. Study aims were to describe baseline features, 1-year follow-up, and baseline predictors of outcome in clinically suspected or biopsy-proven myocarditis (2013 European Society of Cardiology criteria) in adult and paediatric patients from the EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry. METHODS: Five hundred eighty-one (68.0% male) patients, 493 adults, median age 38 (27-52) years, and 88 children, aged 8 (3-13) years, were divided into 3 groups: Group 1 (n = 233), clinically suspected myocarditis with abnormal cardiac magnetic resonance; Group 2 (n = 222), biopsy-proven myocarditis; and Group 3 (n = 126) clinically suspected myocarditis with normal or inconclusive or no cardiac magnetic resonance. Baseline features were analysed overall, in adults vs. children, and among groups. One-year outcome events included death/heart transplantation, ventricular assist device (VAD) or implantable cardioverter defibrillator (ICD) implantation, and hospitalization for cardiac causes. RESULTS: Endomyocardial biopsy, mainly right ventricular, had a similarly low complication rate in children and adults (4.7% vs. 4.9%, P = NS), with no procedure-related death. A classical myocarditis pattern on cardiac magnetic resonance was found in 31.3% of children and in 57.9% of adults with biopsy-proven myocarditis (P < .001). At 1-year follow-up, 11/410 patients (2.7%) died, 7 (1.7%) received a heart transplant, 3 underwent VAD (0.7%), and 16 (3.9%) underwent ICD implantation. Independent predictors at diagnosis of death or heart transplantation or hospitalization or VAD implantation or ICD implantation at 1-year follow-up were lower left ventricular ejection fraction and the need for immunosuppressants for new myocarditis diagnosis refractory to non-aetiology-driven therapy. CONCLUSIONS: Endomyocardial biopsy was safe, and cardiac magnetic resonance using Lake Louise criteria was less sensitive, particularly in children. Virus-negative lymphocytic myocarditis was predominant both in children and adults, and use of immunosuppressive treatments was low. Lower left ventricular ejection fraction and the need for immunosuppressants at diagnosis were independent predictors of unfavourable outcome events at 1 year.
引用
- Caforio ALP, Kaski JP, Gimeno JR, et al. Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry. Eur Heart J. 2024. PMID: 38594778. doi:10.1093/eurheartj/ehae169
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。